PanGen Biotech Inc. (KOSDAQ:222110)
South Korea · Delayed Price · Currency is KRW 6,170.00
+60.00 (0.98%)
At close: May 14, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 82.45 billion as of May 15, 2026. Its market cap has increased by 29.14% in one year.
Market Cap
82.45B
Enterprise Value
69.61B
Revenue
13.42B
Ranking
n/a
PE Ratio
41.85
Stock Price
6,170.00
Market Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 82.45B, a decrease of -51.87%. That is a compound annual growth rate of -6.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 82.45B | 9.11% |
| Dec 30, 2025 | 75.57B | 2.79% |
| Dec 30, 2024 | 73.52B | 0.08% |
| Dec 28, 2023 | 73.46B | 5.85% |
| Dec 29, 2022 | 69.40B | -30.44% |
| Dec 30, 2021 | 99.78B | 1.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TegoScience | 96.08B |
| Choong Ang Vaccine Laboratory | 95.82B |
| SunBio,Inc. | 92.55B |
| CTCBIO | 92.53B |
| KoBioLabs | 91.46B |
| Naturalendo Tech | 75.62B |
| Shaperon | 73.02B |
| Progen | 69.88B |